Memento Medicines
Boston, US · Founded 2025 · Delaware corporation · 5 known investors
Privately-held biotech company developing biologic therapies for retinal diseases
Founders & leadership
WD
William Daley BonificioNamed on SEC filing
SB
Stephen Basil ThomasNamed on SEC filing
NM
Naveen Manu DaryaniNamed on SEC filing
Board
ZS
MK
Megan KrenchBoard director
DH
VK
Vishal KapoorBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$38M disclosed across 1 round · 2026
▶$38MraisedJun 2026 · 7 investors · BiotechnologyRule 506(b)
▶$38MraisedJun 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zach ScheinerDirector
- William Daley BonificioExecutive Officer, Promoter
- Megan KrenchDirector
- Stephen Basil ThomasExecutive Officer, Promoter
- Dmitrij HristodorovDirector
- Naveen Manu DaryaniExecutive Officer, Director, Promoter
- Vishal KapoorDirector
- Offering amount
- $93M
- Amount sold
- $38M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Memento brings home $93M series A souvenir, picks up bispecific for eye diseases - BioSpacebiospace.com · Jun 2026
Memento Medicines Raises $93M in Series A Fundingfinsmes.com · Jun 2026Frequently asked questions
- What does Memento Medicines do?
- Privately-held biotech company developing biologic therapies for retinal diseases
- Who are Memento Medicines's investors?
- Memento Medicines's investors include Sanofi Ventures, Avego BioScience Capital, Forbion, RA Capital, Samsara BioCapital.
- How much funding has Memento Medicines raised?
- Memento Medicines has disclosed $38M raised across 1 round.
- Where is Memento Medicines headquartered?
- Memento Medicines is headquartered in Boston, US.